IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 242 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,619,563 | +17.9% | 895,074 | +30.2% | 0.00% | +50.0% |
| Q2 2023 | $7,313,064 | -11.7% | 687,318 | -12.7% | 0.00% | -33.3% |
| Q1 2023 | $8,280,124 | -18.5% | 787,084 | -4.0% | 0.00% | -25.0% |
| Q4 2022 | $10,163,281 | +811.5% | 820,281 | +661.7% | 0.00% | – |
| Q3 2022 | $1,115,000 | -17.4% | 107,685 | -8.1% | 0.00% | -100.0% |
| Q2 2022 | $1,350,000 | -75.1% | 117,153 | -72.8% | 0.00% | -50.0% |
| Q1 2022 | $5,412,000 | -5.1% | 430,231 | -12.0% | 0.00% | 0.0% |
| Q4 2021 | $5,702,000 | -33.2% | 488,898 | -25.2% | 0.00% | -33.3% |
| Q3 2021 | $8,531,000 | +57.0% | 653,257 | +54.8% | 0.00% | +50.0% |
| Q2 2021 | $5,433,000 | +1151.8% | 422,101 | +987.3% | 0.00% | – |
| Q1 2021 | $434,000 | +3.6% | 38,820 | +5.6% | 0.00% | – |
| Q4 2020 | $419,000 | -29.2% | 36,751 | -44.1% | 0.00% | – |
| Q3 2020 | $592,000 | -56.1% | 65,791 | -49.6% | 0.00% | -100.0% |
| Q2 2020 | $1,348,000 | -70.5% | 130,525 | -71.2% | 0.00% | -50.0% |
| Q1 2020 | $4,570,000 | -54.8% | 452,950 | -40.3% | 0.00% | -50.0% |
| Q4 2019 | $10,101,000 | +25.8% | 758,879 | -18.9% | 0.00% | +33.3% |
| Q3 2019 | $8,032,000 | +73.7% | 935,614 | +121.4% | 0.00% | +50.0% |
| Q2 2019 | $4,623,000 | +1.5% | 422,544 | +5.0% | 0.00% | 0.0% |
| Q1 2019 | $4,555,000 | -49.0% | 402,385 | -53.3% | 0.00% | -50.0% |
| Q4 2018 | $8,928,000 | -32.9% | 861,802 | +19.6% | 0.00% | -20.0% |
| Q3 2018 | $13,297,000 | +216.1% | 720,323 | +227.4% | 0.01% | +150.0% |
| Q2 2018 | $4,207,000 | +75.9% | 220,036 | +42.0% | 0.00% | +100.0% |
| Q1 2018 | $2,392,000 | +649.8% | 154,957 | +627.0% | 0.00% | – |
| Q4 2017 | $319,000 | -60.5% | 21,316 | -58.3% | 0.00% | – |
| Q3 2017 | $807,000 | +241.9% | 51,142 | +309.0% | 0.00% | – |
| Q2 2017 | $236,000 | +2850.0% | 12,504 | +2660.3% | 0.00% | – |
| Q1 2017 | $8,000 | -99.0% | 453 | -99.2% | 0.00% | – |
| Q4 2016 | $828,000 | +41300.0% | 54,173 | +38873.4% | 0.00% | – |
| Q3 2016 | $2,000 | -99.1% | 139 | -99.2% | 0.00% | – |
| Q2 2016 | $227,000 | +138.9% | 17,357 | +98.2% | 0.00% | – |
| Q1 2016 | $95,000 | -92.8% | 8,756 | -92.3% | 0.00% | -100.0% |
| Q4 2015 | $1,320,000 | +4788.9% | 113,856 | +4306.2% | 0.00% | – |
| Q3 2015 | $27,000 | -12.9% | 2,584 | +0.2% | 0.00% | – |
| Q2 2015 | $31,000 | -98.9% | 2,579 | -98.6% | 0.00% | -100.0% |
| Q1 2015 | $2,917,000 | +3177.5% | 182,300 | +3037.2% | 0.00% | – |
| Q4 2014 | $89,000 | – | 5,811 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 1,520,000 | $19,562,000 | 18.54% |
| Sarissa Capital Management LP | 16,390,000 | $210,939,000 | 16.77% |
| Healthcare Value Capital, LLC | 200,000 | $2,574,000 | 5.13% |
| Camber Capital Management LP | 7,500,000 | $96,525,000 | 3.25% |
| 13D Management LLC | 650,455 | $8,371,000 | 2.88% |
| BRIDGER MANAGEMENT, LLC | 2,035,114 | $26,192,000 | 2.44% |
| Brown Capital Management | 18,484,759 | $237,899,000 | 1.80% |
| Healthcare Value Capital, LLC | 50,000 | $644,000 | 1.28% |
| Zebra Capital Management LLC | 53,359 | $687,000 | 0.80% |
| PRICE MICHAEL F | 520,000 | $6,692,000 | 0.74% |